Entering plant-based biotechnologies to advance Robertet’s "Augmented Naturality” strategy Strengthening Robertet’s position ...
As AI tools become more prevalent in the life sciences, biotechnology companies need to evaluate AI’s impact on their ability to protect the results of their research. Recent U.S. Patent and Trademark ...
Jason P Rogers of James & Wells provides a guide to protecting pharmaceutical and biotech inventions in New Zealand, and previews the changes expected under proposed changes to the Patents Act In New ...
The Print on MSN
Genetics, biotechnology, robotics—India’s MoU with Iranian universities are in limbo
A senior professor from Jamia Millia Islamia University told ThePrint that the tenure of most of the university’s ...
AI as defined by the UK Intellectual Property Office (‘UK IPO’) and European Patent Office (‘EPO’) Applications of AI in biotechnology How biotechnology companies can leverage AI to drive innovation ...
At stake in the ongoing patent dispute over the gene-editing tool are rights to the most important new biotechnology of the age and credit for inventing it. The CRISPR patents are back in play. On ...
Masato Iida of Shiga International Patent Office explains how the inventive step obstacle can be cleared when preparing a patent application and presents several case studies based on combination ...
Artificial intelligence is beginning to transform patent practice, but for chemistry and biotech, the challenges remain unique. How well do today’s AI tools truly understand complex scientific ...
The Amendment to the Taiwan Patent Act is expected to come into effect in November 2012. As the government endeavours to stimulate the growth of the biotech and pharmaceutical industries in Taiwan, ...
Kiran Mazumdar-Shaw said India must build biotech sovereignty powered by AI to protect health security and lead the future of medicine ...
One of the greatest transformations in modern medicine arguably began with a corned beef sandwich. It was the late 1960s, and new Department of Medicine Chair Lloyd Hollingsworth “Holly” Smith Jr., MD ...
Artificial intelligence is beginning to transform patent practice, but for chemistry and biotech, the challenges remain unique. How well do today’s AI tools truly understand complex scientific ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results